Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122455) titled 'A real-world cohort study of the entire growth and development cycle of children: analysis of the long-term safety and key factors of rhGH based on a multicenter long-term follow-up database' on April 14.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

Condition: Growth retardation

Intervention: GH treatment group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-01

Target Sample Size: GH treatment group:11500;Non-GH treatment group:23500;

Countries of Recruitment...